U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07886190) titled 'Symptom Monitoring and Management Intervention After CAR-T' on Oct. 14.
Brief Summary: The goal of this study is to refine and test a digital intervention named WAYPOINT to help patients monitor and manage symptoms after CAR-T therapy. The main question this study aims to answer is whether this intervention can be used as planned (i.e, feasible) and whether it is helpful and easy to use for both patients and clinicians (i.e., acceptable).
Study Start Date: March 01, 2027
Study Type: INTERVENTIONAL
Condition:
Chimeric Antigen Receptor T-cell Therapy
Hematologic Malignancy
Intervention:
BEHAVIORAL: WAYPOINT
Digital symptom moni...